Europe Asthma Devices Market was valued at USD 9.3 Billion in 2022 and is projected to reach USD 15.0 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030.
The European asthma devices market has experienced significant growth, driven by technological advancements and evolving industry requirements. This article delves into the various types of asthma devices available in Europe and the specific demands from industries to ensure safety, efficacy, and environmental sustainability.
Types of Asthma Devices in Europe
Asthma management primarily relies on devices that deliver medication directly to the lungs. The main types include:
Pressurized Metered-Dose Inhalers (pMDIs): These inhalers use propellants to deliver a specific dose of medication. They are widely used due to their portability and effectiveness.
Dry Powder Inhalers (DPIs): DPIs deliver medication in powder form, activated by the patient's inhalation. They eliminate the need for propellants, making them more environmentally friendly.
Nebulizers: Devices that convert liquid medication into a fine mist, suitable for patients who may have difficulty using inhalers, such as young children or the elderly.
Industry Requirements and Regulatory Standards
To ensure the safety and effectiveness of asthma devices, manufacturers must adhere to stringent industry requirements and regulatory standards:
ISO 13485 Certification: This standard specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices that consistently meet customer and applicable regulatory requirements. Compliance with ISO 13485 is often seen as the first step in fulfilling European regulatory obligations.
IEC 60601 Compliance: This series of technical standards ensures the safety and essential performance of medical electrical equipment. Adherence to IEC 60601 is crucial for the commercialization of electrical medical equipment in many countries.
Unique Device Identification (UDI): The EU has adopted the UDI system under the Medical Devices Regulation (MDR) and In-vitro Diagnostic Regulation (IVDR). This system enhances the traceability of medical devices, ensuring that devices can be effectively monitored and recalled if necessary.
Environmental Considerations and Industry Response
Environmental sustainability has become a focal point in the development of asthma devices:
Reducing Greenhouse Gas Emissions: Traditional pMDIs contain hydrofluorocarbon (HFC) propellants, which have a high global warming potential. Pharmaceutical companies like GSK and AstraZeneca are developing inhalers with lower carbon footprints. GSK aims to modify the gas propellant in its Ventolin inhaler, potentially reducing the company's carbon emissions by over 40%. Similarly, AstraZeneca plans to seek regulatory approval for a low-carbon version of its Breztri inhaler, which could decrease greenhouse gas emissions by nearly a fifth.
Shift to Eco-friendly Inhalers: Health authorities are reconsidering the prescription of traditional blue inhalers due to their environmental impact. In the UK, guidelines now recommend combination inhalers containing steroids to reduce lung inflammation and prevent asthma attacks, offering a more effective and eco-friendly option.
Market Trends and Future Outlook
The European asthma therapeutics market generated a revenue of USD 5,251.2 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2030. Anti-inflammatories were the largest revenue-generating drug class in 2023, while combination therapy is projected to be the fastest-growing segment during the forecast period. The UK is anticipated to register the highest CAGR in the region from 2024 to 2030.
In conclusion, the European asthma devices market is undergoing significant transformation, driven by technological advancements, stringent regulatory standards, and a heightened focus on environmental sustainability. Manufacturers are adapting to these changes by developing innovative, eco-friendly devices that comply with rigorous industry requirements, ensuring both patient safety and environmental protection.
Get an In-Depth Research Analysis of the Europe Asthma Devices Market Size And Forecast [2025-2032]
GlaxoSmithKline
Merck & Co
3M
Aristopharma
SRS PHARMACEUTICALS
AstraZeneca
Baxter
Boehringer Ingelheim
Koninklijke Philips
GlaxoSmithKline
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Asthma Devices Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Asthma Devices Market
Inhalers
Nebulizers
Spacers & Valves
Chronic Asthma
Allergic Asthma
Exercise-Induced Asthma
Hospitals
Clinics
Home Care Settings
Ambulatory Surgical Centers
Smart Inhalers
Metered Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Pharmacies
Online Retailers
Hospitals & Clinics
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Asthma Devices Market Research Analysis
1. Introduction of the Europe Asthma Devices Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Asthma Devices Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Asthma Devices Market, By Type
6. Europe Asthma Devices Market, By Application
7. Europe Asthma Devices Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Asthma Devices Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/